Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Delays in U.S. Postal Service deliveries have exposed the dangers of prescription drug mail order services.

CVS Customers Stock Up as USPS Delays Expose Pharmacy Mail Prescription Risks

Delta Air Lines

The airline is working to restore consumer confidence in flying.

Delta, CVS Partner to Accelerate Airline Coronavirus Testing

WOONSOCKET, R.I., Aug. 18, 2020 /PRNewswire/ -- Aetna, a CVS Health (NYSE:CVS) company, has announced the launch of the Attain Games, a virtual event for users of the Attain by Aetna app.

Aetna Announces Attain Games Challenge with Support and Participation of World-Renowned Athletes

Sanofi

Flu season is nearly upon us. Here’s how you can get a flu shot without worrying about going into the doctor’s office.

Sanofi and CVS are building COVID-safe flu vaccination stations

Walgreens

U.S. drugstore chains led by Walgreens and CVS Health are rolling out an unprecedented early push for Americans to get vaccinated at their pharmacies for the seasonal flu before that virus converges with the Covid-19 pandemic

CVS, Walgreens Lead Unprecedented Flu Season Prep As Covid-19 Converges

After a 23% rise since the March 23 lows of this year, at the current price of around $65 per share we believe CVS Health’s stock looks attractive and it has significant room for growth. CVS stock has moved from $53 to $64 off the recent bottom compared to the S&P which moved 50%.

CVS Health Stock Appears Oversold At $65

Kroger

Kroger and CVS Health are both pitching Covid-19 testing programs to employers to help them reopen and operate safely as the pandemic continues.

With test delays across country, Kroger and CVS Health say they can help businesses, college campuses

CVS Deep Dive: A Case To Buy Shares Now

CVS Health Corp's (NYSE: CVS) second-quarter earnings report can be defined as "more good than bad" yet the stock still trades at a discounted valuation, according to BofA Securities.

Analyst Breaks Down CVS Health's 'Complicated' Quarter

CVS Health is back on track with the rollout its new health hub concept to 1,500 stores across the U. S. within the next two years despite the continuing spread of the coronavirus strain Covid-19.

CVS Health Hub Construction Back On Track After Covid-19 Shutdowns

CVS Health: Corner Store And Healthcare Transformed

An unprecedented demand surge for flu prevention and treatments in the second half of 2020 will spark big gains in CVS stock.

CVS Stock May Surge as People Batten Down for the Coming Flu Season

GLENDALE, Ariz., Aug. 7, 2020 /PRNewswire/ -- CVS Health today announced it has launched free rapid COVID-19 testing at 6030 North 43rd.

CVS Health Expands Rapid COVID-19 Testing in Phoenix Area

CVS Health Corp. (NYSE:CVS) recently reported second-quarter earnings results that beat Wall Street’s estimates on both revenue and earnings front.

The Market Continues to Misprice CVS Health

Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.

3 Investing Facts About Required Minimum Distributions You Need to Know - August 06, 2020

AbbVie

AmerisourceBergen

Aflac

AvalonBay Communities

Broadcom

Bristol-Myers

Federal Realty Investment Trust

General Dynamics

Intel

Prudential Financial

Reinsurance Group of America

Snap-on

Simon Property Group

STORE Capital

Toronto-Dominion Bank

The time has come for us to look at just what sort of companies may be appealing to invest in during August.

August 2020 Stocks - Financials, Real Estate, Industrials, IT And Pharma

American Airlines

Boeing

Disney

Disney's shares surge on the growth of its streaming business, CVS beats expectations, and the airline industry is hoping for another round of government support.

S&P 500 Gains 21 Points: Disney and CVS Health Earnings, American Airlines and Boeing Stocks Rally

Before the opening ball on Aug. 5, CVS Health Corp. (NYSE:CVS) released its second-quarter results that topped Wall Street’s expectations.

What Investors Should Know About CVS Health’s 2nd-Quarter Results

CVS (CVS) earnings for the pharmacy company's second quarter of 2020 have its stock down on Wednesday despite beating estimates.
The post CVS Earnings: CVS Stock Ticks 1% Lower Despite Big Q2 Beat appeared first on InvestorPlace.

CVS Earnings: CVS Stock Ticks 1% Lower Despite Big Q2 Beat

CVS Health Corporation (CVS) CEO Larry Merlo on Q2 2020 Results - Earnings Call Transcript

CVS Health (NYSE: CVS) published its quarterly financial results on Wednesday that topped analysts’ estimates for earnings and revenue. The company also raised its guidance for the full fiscal year as it expressed confidence that it was well-positioned to combat the economic impact of COVID-19.

CVS Health tops analysts’ estimates for earnings and revenue in Q2

CVS Health's (CVS) Health Care Benefits segment registers membership growth in Q2.

CVS Health (CVS) Q2 Earnings Top Estimates, 2020 View Up

CVS Health has rolled out thousands of Covid-19 test sites and launched a new business-to-business testing program.

With pandemic, CVS sees big business opportunities with Covid-19 testing, flu shots

The healthcare giant's Q2 revenue growth was held back by the coronavirus outbreak. But its bottom line improved significantly.

CVS Health Crushes Q2 Earnings Estimates Thanks to COVID-19

CVS Health Corp. (NYSE: CVS) reported second-quarter 2020 results before markets opened Wednesday.

News for CVS Health Stock (CVS)